Limited Ability of the Proton-Pump Inhibitor Test to Identify Patients With Gastroesophageal Reflux Disease

Clinical Gastroenterology and Hepatology

Volumn 10, Issue 12, 2012, Pages 1360-1366

  Bytzer, Peter ^a   Jones, Roger ^b   Vakil, Nimish ^c   Junghard, Ola ^d   Lind, Tore ^d   Wernersson, Börje ^d   Dent, John ^e  

^a University of Køge   (Denmark)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d ASTRAZENECA R AND D   (Sweden)

^e ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Acid Reflux; Dyspepsia; Esomeprazole.; Esophagitis

Indexed keywords

ESOMEPRAZOLE; PLACEBO;

ARTICLE; BLOATING; CONTROLLED STUDY; DYSPHAGIA; EPIGASTRIC DISCOMFORT; EPIGASTRIC PAIN; ESOPHAGEAL PH MONITORING; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE; QUESTIONNAIRE; REFLUX ESOPHAGITIS; SINGLE BLIND PROCEDURE; THORAX PAIN; TREATMENT RESPONSE;

CLINICAL MEDICINE; ESOMEPRAZOLE SODIUM; ESOPHAGEAL PH MONITORING; ESOPHAGOSCOPY; GASTROESOPHAGEAL REFLUX; HUMANS; PLACEBOS; PRIMARY HEALTH CARE; PROTON PUMP INHIBITORS; QUESTIONNAIRES; SENSITIVITY AND SPECIFICITY; SINGLE-BLIND METHOD;

EID: 84869465551     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2012.06.030     Document Type: Article

References (23)

1. Numans M.E., Lau J., De Wit N.J., et al. Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics. Ann Intern Med 2004, 140:518-527.
2. Tytgat G.N., McColl K., Tack J., et al. New algorithm for the treatment of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2008, 27:249-256.
3. Kahrilas P.J., Shaheen N.J., Vaezi M.F., et al. American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease. Gastroenterology 2008, 135:1392-1403.
4. Dent J., Vakil N., Jones R., et al. Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the DIAMOND study. Gut 2010, 59:714-721.
5. Shaw M.J., Talley N.J., Beebe T.J., et al. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol 2001, 96:52-57.
6. Vakil N. Review article: how valuable are proton-pump inhibitors in establishing a diagnosis of gastro-oesophageal reflux disease?. Aliment Pharmacol Ther 2005, 22(Suppl 1):64-69.
7. Fass R., Ofman J.J., Gralnek I.M., et al. Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease. Arch Intern Med 1999, 159:2161-2168.
8. Ofman J.J., Dorn G.H., Fennerty M.B., et al. The clinical and economic impact of competing management strategies for gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2002, 16:261-273.
9. Aanen M.C., Weusten B.L., Numans M.E., et al. Diagnostic value of the proton pump inhibitor test for gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther 2006, 24:1377-1384.
10. des Varannes S.B., Sacher-Huvelin S., Vavasseur F., et al. Rabeprazole test for the diagnosis of gastro-oesophageal reflux disease: results of a study in a primary care setting. World J Gastroenterol 2006, 12:2569-2573.
11. Monés J. Diagnostic value of potent acid inhibition in gastro-oesophageal reflux disease. Drugs 2005, 65(Suppl 1):35-42.
12. van Pinxteren B., Numans M.E., Lau J., et al. Short-term treatment of gastroesophageal reflux disease. J Gen Intern Med 2003, 18:755-763.
13. Juul-Hansen P., Rydning A. Endoscopy-negative reflux disease: what is the value of a proton-pump inhibitor test in everyday clinical practice?. Scand J Gastroenterol 2003, 38:1200-1203.
14. Galmiche J.P., Barthelemy P., Hamelin B. Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride. Aliment Pharmacol Ther 1997, 11:765-773.
15. Hatlebakk J.G., Hyggen A., Madsen P.H., et al. Heartburn treatment in primary care: randomised, double blind study for 8 weeks. BMJ 1999, 319:550-553.
16. Johnsson F., Weywadt L., Solhaug J.H., et al. One-week omeprazole treatment in the diagnosis of gastro-oesophageal reflux disease. Scand J Gastroenterol 1998, 33:15-20.
17. Venables T.L., Newland R.D., Patel A.C., et al. Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice. Scand J Gastroenterol 1997, 32:965-973.
18. Bate C.M., Riley S.A., Chapman R.W., et al. Evaluation of omeprazole as a cost-effective diagnostic test for gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1999, 13:59-66.
19. Fass R., Ofman J.J., Sampliner R.E., et al. The omeprazole test is as sensitive as 24-h oesophageal pH monitoring in diagnosing gastro-oesophageal reflux disease in symptomatic patients with erosive oesophagitis. Aliment Pharmacol Ther 2000, 14:389-396.
20. Juul-Hansen P., Rydning A., Jacobsen C.D., et al. High-dose proton-pump inhibitors as a diagnostic test of gastro-oesophageal reflux disease in endoscopic-negative patients. Scand J Gastroenterol 2001, 36:806-810.
21. Schenk B.E., Kuipers E.J., Klinkenberg-Knol E.C., et al. Omeprazole as a diagnostic tool in gastroesophageal reflux disease. Am J Gastroenterol 1997, 92:1997-2000.
22. Meineche-Schmidt V. Empiric treatment with high and standard dose of omeprazole in general practice: two-week randomized placebo-controlled trial and 12-month follow-up of health-care consumption. Am J Gastroenterol 2004, 99:1050-1058.
23. Johnsson F., Hatlebakk J.G., Klintenberg A.C., et al. One-week esomeprazole treatment: an effective confirmatory test in patients with suspected gastroesophageal reflux disease. Scand J Gastroenterol 2003, 38:354-359.